KFDA approved Lyrica for neuropathic pain.

Published: 2005-06-28 06:58:00
Updated: 2005-06-28 06:58:00
Pfizer Korea said that the KFDA approved Lyrica (pregabalin) for neuropathic pain associated with diabetic peripheral neuropathy and adjunctive therapy in the treatment of partial seizures in adults on June 14.

Lyrica shows a new mode of action by selectively binding with alpha 2 delta protein...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.